Association of low angiomotin-p130 and high YAP1 nuclear expression with adverse prognosis in epithelial ovarian cancer

• Junna Cai ^[1] ; Xiaorui Han ^[2] ; Meng Li ^[2] ; Xiaoli Liu ^[2] ; Fengying Zhang ^[2] ; Xiaohua Wu ^[1]
  1. [1] Hebei Medical University,PR. China
  2. [2] Xingtai People’s Hospital, Xingtai, Hebei, PR China
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 40, Nº. 1, 2025, págs. 57-65
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Objectives. The aim of our study was to examine the association of Angiomotin (Amot-p130) and Yes-associated protein 1 (YAP1) expressions and their prognostic significance in epithelial ovarian cancer (EOC).

    Methods. A total of 100 primary EOC samples were obtained for immunohistochemical analysis of Amotp130 and YAP1 expressions. Correlation analysis was performed between Amot-p130 or YAP1 and clinical factors. The overall survival time was calculated.

    Results. Low Amot-p130 and high YAP1 nuclear expression were identified in 34 and 56 of 100 EOC tissues, respectively. Both low Amot-p130 and high YAP1 nuclear expression were associated with advanced tumor stage, high-grade carcinoma, and non-response to chemotherapy (p<0.05). They were also associated with shorter overall survival time (p<0.05) by log-rank test. A marker of low Amot-p130 and high YAP1 expression was associated with high-grade ovarian carcinoma, latestage disease, non-response to chemotherapy, and shorter overall survival time (p<0.05).

    Conclusions. Low Amot-p130 and high YAP1 nuclear expression can provide additional prognostic information for patients with EOC. A marker of low Amot-p130 and high YAP1 expression may be a potent predictor of poor prognosis in patients with epithelial ovarian cancer.